REHOVOT, Israel, Aug. 31, 2026 — CollPlant Biotechnologies Ltd. today announced that it has signed a definitive agreement to acquire LightSolver Ltd., an Israeli deep-tech company pioneering a fundamentally new computing architecture based on lasers. The acquisition is expected to close this week.

CollPlant is acquiring LightSolver utilizing an equity-centric consideration structure comprising upfront closing shares, alongside pre-funded warrants and milestone-based warrants directly tied to LightSolver meeting specific technological and commercial objectives.

LightSolver has developed the Laser Processing Unit (LPU), an all-optical working computing platform that uses the physical interaction of lasers to perform computation. Rather than relying exclusively on electronic transistors to execute mathematical operations and move data between processing and memory, the LPU maps mathematical problems onto an optical system in which large numbers of variables can interact simultaneously.

By using light itself as the computational medium, the LPU is designed to perform massively parallel computation with exceptional speed and energy efficiency.

LightSolver’s quantum-inspired architecture captures certain advantages of physical, highly parallel computation in a room-temperature platform while avoiding many of the practical constraints associated with quantum computing.

LightSolver is targeting some of the world’s most computationally demanding problems, using its LPU to accelerate large-scale linear systems, optimization and PDEs-the mathematics powering everything from robotics and Physical AI, weather prediction to plasma physics, chip design, new materials and drug discovery, and real-time mission-critical decision-making.

“We are excited to announce this transformational acquisition of LightSolver, which opens an extraordinary new growth vector for CollPlant in the high-performance photonic computing and supercomputing space,” said Yehiel Tal, Chairperson and Chief Executive Officer of CollPlant, “While entering the photonics market, CollPlant remains fully committed to regenerative medicine and medical aesthetics. To this end, we are actively pursuing strategic collaborations with global leaders interested in advancing, integrating, or otherwise leveraging our technology and capabilities.”

Dr. Ruti Ben Shlomi, founder and CEO of LightSolver, commented, “Computing is reaching an inflection point. We believe the next great leap will come not from making transistors smaller, but from changing the very medium of computing – from electrons to light – unlocking a new era of speed and energy efficiency. We have turned that idea from fundamental physics into a working machine. As we move toward commercial availability, our ambition is for the LPU to become a new computing layer alongside CPUs and GPUs – compressing computational workloads that can take minutes, hours or even weeks into milliseconds of LPU computation.”

Eran Rotem, Deputy CEO and Chief Financial Officer of CollPlant stated, “This transaction marks CollPlant’s entry into a market with massive growth potential, executed through a highly disciplined approach to capital allocation. Our goal is to support the continued development and commercialization of LightSolver’s technology while creating a new strategic growth opportunity for CollPlant.”